Evaluation of Correlates of Protective Efficacy of Seasonal Live Attenuated Influenza Vaccine (LAIV) by Utilization of a Human Challenge Model of Infection With Wild-type (wt) Influenza A/California/2009 (H1N1)-Like Virus
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 01 Dec 2017
At a glance
- Drugs Influenza virus vaccine live (Primary)
- Indications Influenza A virus H1N1 subtype; Influenza virus infections
- Focus Adverse reactions; Therapeutic Use
- 27 Nov 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 18 Apr 2017 Status changed from recruiting to not yet recruiting.
- 08 Nov 2016 New trial record